
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
EPB41L5 promotes EMT through the ERK/p38 MAPK signaling pathway in esophageal squamous cell carcinoma
Shihao Bao, Zhiqi Ji, Mo Shi, et al.
Pathology - Research and Practice (2021) Vol. 228, pp. 153682-153682
Open Access | Times Cited: 17
Shihao Bao, Zhiqi Ji, Mo Shi, et al.
Pathology - Research and Practice (2021) Vol. 228, pp. 153682-153682
Open Access | Times Cited: 17
Showing 17 citing articles:
Biomimetic Nanocomposites Camouflaged with Hybrid Cell Membranes for Accurate Therapy of Early‐Stage Glioma
Siyu Chi, Li Zhang, Hemei Cheng, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 29
Closed Access | Times Cited: 44
Siyu Chi, Li Zhang, Hemei Cheng, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 29
Closed Access | Times Cited: 44
CBX2 Deletion Suppresses Growth and Metastasis of Colorectal Cancer by Mettl3-p38/ERK MAPK Signalling Pathway
Rui Sun, Xucan Tu, Shixin Chan, et al.
Journal of Cancer (2024) Vol. 15, Iss. 8, pp. 2123-2136
Open Access | Times Cited: 8
Rui Sun, Xucan Tu, Shixin Chan, et al.
Journal of Cancer (2024) Vol. 15, Iss. 8, pp. 2123-2136
Open Access | Times Cited: 8
Suppression of SMOC2 alleviates myocardial fibrosis via the ILK/p38 pathway
Huang Rui, Fang Zhao, Yuhua Lei, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 9
Open Access | Times Cited: 14
Huang Rui, Fang Zhao, Yuhua Lei, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 9
Open Access | Times Cited: 14
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches
Maria Fortunata Lofiego, Francesca Piazzini, Francesca Pia Caruso, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Maria Fortunata Lofiego, Francesca Piazzini, Francesca Pia Caruso, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Biomimetic Nanocomposites Camouflaged with Hybrid Cell Membranes for Accurate Therapy of Early‐Stage Glioma
Siyu Chi, Li Zhang, Hemei Cheng, et al.
Angewandte Chemie (2023) Vol. 135, Iss. 29
Closed Access | Times Cited: 11
Siyu Chi, Li Zhang, Hemei Cheng, et al.
Angewandte Chemie (2023) Vol. 135, Iss. 29
Closed Access | Times Cited: 11
Exosomatic miR‐1246 Promotes Hepatocellular Carcinoma Progression via FSTL5 and ERK/p38 MAPK Pathway
Wenju Chen, Yingjie Dai, Wan‐hong Gu, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Wenju Chen, Yingjie Dai, Wan‐hong Gu, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Knockdown of PPP2R2B inhibits pancreatic cancer progression via the ERK/MAPK pathway by modulating EMT and apoptosis
Fangfang Han, Zhou Chen, Cheng Ye, et al.
Research Square (Research Square) (2025)
Closed Access
Fangfang Han, Zhou Chen, Cheng Ye, et al.
Research Square (Research Square) (2025)
Closed Access
Demethylated miR-184 regulates EPB41L5 and downregulates Notch signaling to inhibit metastasis in colorectal cancer
Shu Yin, Xiaohui Cai, Xinhui Yang, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 3
Closed Access
Shu Yin, Xiaohui Cai, Xinhui Yang, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 3
Closed Access
ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5
Ji‐Hoon Jeong, Seung‐Ho Park, Hyunhee Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 1, pp. 43-54
Open Access | Times Cited: 9
Ji‐Hoon Jeong, Seung‐Ho Park, Hyunhee Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 1, pp. 43-54
Open Access | Times Cited: 9
Knockdown of growth differentiation factor-15 restrains prostate cancer through regulating MAPK/ERK signaling pathway
Minggen Yang, Miaolin Guo, Chenqiang Su, et al.
Cellular and Molecular Biology (2024) Vol. 70, Iss. 3, pp. 162-167
Open Access | Times Cited: 3
Minggen Yang, Miaolin Guo, Chenqiang Su, et al.
Cellular and Molecular Biology (2024) Vol. 70, Iss. 3, pp. 162-167
Open Access | Times Cited: 3
The abnormal expression of circ-ARAP2 promotes ESCC progression through regulating miR-761/FOXM1 axis-mediated stemness and the endothelial–mesenchymal transition
Pei Xu, Lei Wang, Qingtao Liu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Pei Xu, Lei Wang, Qingtao Liu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies
Daniel Pouliquen, Alice Boissard, Cécile Henry, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Daniel Pouliquen, Alice Boissard, Cécile Henry, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Using single‐cell RNA sequencing and bulk RNA sequencing data to reveal a correlation between smoking and neutrophil activation in esophageal carcinoma patients
Yunhuan Ba, Xinyu Gu
Environmental Toxicology (2024) Vol. 39, Iss. 10, pp. 4689-4699
Closed Access | Times Cited: 1
Yunhuan Ba, Xinyu Gu
Environmental Toxicology (2024) Vol. 39, Iss. 10, pp. 4689-4699
Closed Access | Times Cited: 1
EPB41L3 Inhibits the Progression of Cervical Cancer Via the ERK/p38 MAPK Signaling Pathway
Gulixian Tuerxun, Wenyun Li, Guligeina Abudurexiti, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 1
Gulixian Tuerxun, Wenyun Li, Guligeina Abudurexiti, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 1
Arntl-induced upregulation of DUSP1 inhibits tumor progression in esophageal squamous cell carcinoma by inactivating ERK signaling
Jianjun Wang, Qifan Jia, Jingyao Sun, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access
Jianjun Wang, Qifan Jia, Jingyao Sun, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access
The Role of PPP2R2B in Pancreatic Cancer Progression: A Novel Pro-Cancer Factor
Fangfang Han, Zhou Chen, Cheng Ye, et al.
Research Square (Research Square) (2024)
Open Access
Fangfang Han, Zhou Chen, Cheng Ye, et al.
Research Square (Research Square) (2024)
Open Access
ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5
Kyung‐Chul Choi, Ji‐Hoon Jeong, Seung‐Ho Park, et al.
Research Square (Research Square) (2022)
Open Access
Kyung‐Chul Choi, Ji‐Hoon Jeong, Seung‐Ho Park, et al.
Research Square (Research Square) (2022)
Open Access